Total reported value
$238.8M
Reporting period: 2026-03-31 · Number of holdings: 21
Pfizer Inc disclosed 21 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $238.8M and a quarterly turnover rate of 31.1%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "P"
Trim WVE
0.0% -$19.9M
Add ALLO
0.0% $19.6M
Add ORIC
-11.1% $13.7M
Trim ARVN
0.0% -$6.1M
Trim CELC
-15.4% -$3.5M
Trim CRDF
0.0% -$3.0M
Showing top 18 holdings (of 21 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 24.14% | +5.54% | -11.08% | |
| 2 | ALLO | Allogene Therapeutics INC | Stock-Other | 20.85% | +8.09% | — | |
| 3 | ARVN | Arvinas INC | Stock-Other | 14.63% | -2.71% | — | |
| 4 | CELC | Celcuity INC | Stock-Other | 13.13% | -1.61% | -15.38% | |
| 5 | ✓ | Zura Bio LTD | Stock-Other | 7.05% | +0.47% | -4.41% | |
| 6 | WVE | Wave Life Sciences Ltd. | Stock-Other | 5.00% | -8.48% | — | |
| 7 | PYXS | Pyxis Oncology INC | Stock-Other | 3.86% | +0.44% | — | |
| 8 | CRBU | Caribou Biosciences INC | Stock-Other | 3.50% | +0.35% | — | |
| 9 | SPRO | Spero Therapeutics INC | Stock-Other | 2.31% | -0.02% | — | |
| 10 | BHVN | Biohaven Ltd. | Stock-Other | 1.77% | -0.64% | — | |
| 11 | CRDF | Cardiff Oncology INC | Stock-Other | 1.57% | -1.30% | — | |
| 12 | ZNTL | Zentalis Pharmaceuticals INC | Stock-Other | 0.84% | +0.30% | — | |
| 13 | NXTC | Nextcure INC | Stock-Other | 0.64% | -0.31% | -2.72% | |
| 14 | AGMB | Agomab Therapeutics NV | Stock-Other | 0.34% | +0.34% | NEW | |
| 15 | QTTB | Q32 Bio INC | Stock-Other | 0.31% | -0.08% | -63.42% | |
| 16 | BOLT | Bolt Biotherapeutics INC | Stock-Other | 0.06% | -0.01% | — | |
| 17 | DNA | Ginkgo Bioworks Holdings INC | Stock-Other | 0.01% | — | — | |
| 18 | SENS1GBP | Senseonics Holdings INC | Stock-Other | 0.01% | — | — |
Performance for Q3 2026
-12.4%
Performance Last 4 Quarters
-9.7%
Based on 69% of reported portfolio value with available pricing
Not enough sector-mapped data yet
Pfizer Inc's most significant position changes for 2026-03-31: Sold out: An2 Therapeutics INC (ANTX); New buy: Agomab Therapeutics NV (AGMB); Trim: Oric Pharmaceuticals INC (ORIC) — shares -11.08%; Trim: Celcuity INC (CELC) — shares -15.38%; Trim: Zura Bio LTD — shares -4.41%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ALLO | Allogene Therapeutics INC | +8.1% | — | Unchanged |
| 2 | ORIC | Oric Pharmaceuticals INC | +5.5% | -11.08% | Trim |
| 3 | ✓ | Zura Bio LTD | +0.5% | -4.41% | Trim |
| 4 | PYXS | Pyxis Oncology INC | +0.4% | — | Unchanged |
| 5 | CRBU | Caribou Biosciences INC | +0.4% | — | Unchanged |
| 6 | ZNTL | Zentalis Pharmaceuticals INC | +0.3% | — | Unchanged |
| 7 | DNA | Ginkgo Bioworks Holdings INC | — | — | Unchanged |
| 8 | SENS1GBP | Senseonics Holdings INC | — | — | Unchanged |
| 9 | BOLT | Bolt Biotherapeutics INC | 0% | — | Unchanged |
| 10 | SPRO | Spero Therapeutics INC | 0% | — | Unchanged |
| 11 | QTTB | Q32 Bio INC | -0.1% | -63.42% | Trim |
| 12 | NXTC | Nextcure INC | -0.3% | -2.72% | Trim |
| 13 | BHVN | Biohaven Ltd. | -0.6% | — | Unchanged |
| 14 | CRDF | Cardiff Oncology INC | -1.3% | — | Unchanged |
| 15 | CELC | Celcuity INC | -1.6% | -15.38% | Trim |
| 16 | ARVN | Arvinas INC | -2.7% | — | Unchanged |
| 17 | WVE | Wave Life Sciences Ltd. | -8.5% | — | Unchanged |
| 18 | ANTX | An2 Therapeutics INC | — | EXIT | Sold out |
| 19 | AGMB | Agomab Therapeutics NV | — | NEW | New buy |
Institutions with a similar AUM
CIK 0000029915
Total reported value
$238.8M
6 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002107791
Total reported value
$238.8M
2 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001923052
Total reported value
$238.8M
97 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001911010
Total reported value
$616.4M
15 stks
2024-12-31
Stale — no recent filing
2 of the top 5 holdings overlap, including Oric Pharmaceuticals INC
CIK 0001224962
Total reported value
$5.1B
94 stks
2026-03-31
1 of the top 5 holdings overlap, including Celcuity INC
CIK 0001232621
Total reported value
$2.0B
51 stks
2026-03-31
1 of the top 5 holdings overlap, including Celcuity INC